swii.ch Logo
Rare disease patient insight & strategy
Get in touch
swii.ch Logo
Rare disease patient insight & engagement 
Get in touch

Embracing Niche Social Channels for Diverse Patient Recruitment in Clinical Trials

Back to posts

Clinical trial recruitment for rare diseases poses unique challenges, including finding diverse patient populations that are often scattered geographically.

Traditional recruitment methods may not effectively reach these individuals. However, by embracing niche social channels and leveraging patient social behavior insights, researchers can define targeted recruitment strategies and messaging that resonate with specific patient preferences based on age, ethnicity, and culture. 

The Importance of Niche Social Channels

Niche social channels cater to specific interests, communities, or demographics, allowing for more targeted communication. For rare disease clinical trial recruitment, these channels offer an opportunity to connect with patient groups that may not be as active on mainstream platforms.

Engaging patients on channels where they are most comfortable and active can lead to more meaningful interactions and higher response rates.

Patient Social Behavior Insights: Defining Recruitment Strategy and Messaging

Understanding patient social behavior is essential for crafting effective recruitment strategies and messaging. By analyzing data on patient preferences, online habits, and engagement patterns, researchers can tailor their approach to specific patient groups. 

Age and Ethnicity as Factors in Niche Social Channel Preference

Patients' age and ethnicity can influence their social media usage preferences. Younger individuals are more likely to be active on platforms such as TikTok and Snapchat, while older populations may gravitate towards Facebook and LinkedIn. Similarly, diverse patient groups may prefer niche social channels that cater to their cultural interests and languages.

  • Diverse Asian Patient Groups: WeChat and LINE are popular among Asian communities, especially in China and Japan, respectively. These platforms offer various functionalities, including messaging, social networking, and payment services, making them ideal for reaching out to diverse Asian patient populations.
  • Afro-Caribbean Patient Groups: WhatsApp is widely used by Afro-Caribbean communities for its ease of communication and ability to form group chats. This platform can facilitate direct and personalized outreach to these patient groups.
  • French Patient Groups: Leetchi, a platform for crowdfunding and group payments, is popular among French communities. Utilizing this platform can help researchers connect with French patients interested in participating in clinical trials.
  • Spanish Patient Groups: Taringa! is a Spanish-language social platform popular in Latin America. Researchers can use this platform to engage with Spanish-speaking patient populations in the region.
  • German Patient Groups: XING, a professional networking platform similar to LinkedIn, is widely used by German-speaking professionals. Utilizing XING can help researchers connect with German patients interested in clinical trial participation.

Examples of Successful Clinical Trial Recruitment Campaigns using Niche Social Channels

a. The Global Gaucher Community, a rare disease patient advocacy group, launched a successful clinical trial recruitment campaign on WeChat to reach out to Chinese patients with Gaucher disease. By leveraging the platform's multimedia capabilities and engaging influencers in the community, the campaign achieved a significant increase in trial interest and participation.

b. The "Rare Disease Champions" campaign used WhatsApp to recruit Afro-Caribbean patients for a sickle cell disease clinical trial. By forming dedicated patient support groups on the platform and collaborating with local healthcare providers, the campaign successfully enrolled a diverse group of participants.

c. A Spanish clinical trial recruitment campaign for Pompe disease targeted Spanish-speaking patient communities on Taringa!. The campaign utilized educational content, patient testimonials, and a call to action to raise awareness about the trial and encourage participation.


Embracing niche social channels for diverse patient recruitment in rare disease clinical trials offers a strategic advantage in reaching underrepresented populations. By leveraging patient social behavior insights to define recruitment strategies and messaging, researchers can foster meaningful engagement and improve trial participation rates.

Utilising platforms that cater to specific age groups, ethnicities, and language preferences allows for a more personalized approach, ensuring that clinical trial information reaches the right audiences. 


  • Manciaux A, Riva A, Pérez-Ramirez U. How Taringa! was Born: The Creation of an Argentinean ‘Latin’ Company. Social Media + Society. 2018;4(2):205630511876910.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-473. doi:10.7326/M18-0850.

Swii.ch Health is a leading organization specializing in patient behavioral insights and engagement strategy. Their team of experts can guide researchers in optimizing their recruitment efforts on niche social channels, fostering inclusive participation, and ultimately advancing medical research for the benefit of diverse patient populations.

swii.ch Logo
Rare disease patient insight & engagement
© swii.ch Health 2024.
Privacy Policy
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.